A detailed history of Israel Englander (Millennium Management LLC) transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 16,900 shares of PYXS stock, worth $28,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,900
Previous 1,336,908 98.74%
Holding current value
$28,561
Previous $4.43 Million 98.6%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.83 - $3.94 $1.61 Million - $2.25 Million
570,070 Added 42.64%
1,906,978 $7 Million
Q2 2024

Aug 14, 2024

BUY
$3.06 - $5.58 $2.31 Million - $4.21 Million
753,899 Added 129.31%
1,336,908 $4.43 Million
Q1 2024

May 15, 2024

BUY
$2.03 - $6.59 $1.16 Million - $3.75 Million
569,737 Added 4292.77%
583,009 $2.48 Million
Q4 2023

Feb 14, 2024

SELL
$1.4 - $2.09 $24,648 - $36,796
-17,606 Reduced 57.02%
13,272 $23,000
Q2 2023

Aug 14, 2023

BUY
$2.46 - $4.07 $75,959 - $125,673
30,878 New
30,878 $79,000
Q4 2022

Feb 14, 2023

SELL
$1.14 - $2.0 $66,694 - $117,008
-58,504 Reduced 65.12%
31,334 $42,000
Q3 2022

Nov 14, 2022

SELL
$1.88 - $3.03 $99,596 - $160,520
-52,977 Reduced 37.09%
89,838 $177,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.